Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome
Journal of Clinical Medicine · 30.06.2023 · 12 (13) · 4435
DOI: 10.3390/jcm12134435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.06.2023. Verfasst von Ying-Ju Ou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Medical University, Research Center for Precision Environmental Medicine, Ministry of Education (MOE).
Abstract (Originalsprache)
(1)
Background
We aimed to explore the associations between menopause, postmenopausal hormone therapy, and metabolic syndrome in a large community-based group of Asian women. (2)
Methods
This is a cross-sectional study in which we enrolled women aged 30 to 70 years with sufficient information about menopausal status from the Taiwan Biobank. The definition for metabolic syndrome used in this study aligns with the Bureau of Health Promotion’s (Taiwan) proposed definition. (3)
Results
A total of 17,460 women were recruited. The postmenopausal group had a higher metabolic syndrome prevalence (30% vs. 14%) and 1.17 times higher odds ratio (OR) than the premenopausal group (95% confidence interval [CI] = 1.02 to 1.33). Regarding the types of menopause, surgical menopause was associated with metabolic syndrome (OR = 1.40; 95% CI = 1.20 to 1.63); however, natural menopause was not associated with metabolic syndrome. Interestingly, postmenopausal hormone therapy was associated with a lower risk of metabolic syndrome in the women with natural menopause (OR = 0.79; 95% CI = 0.70 to 0.89), but not in those with surgical menopause. (4)
Conclusions
Our results suggest that menopause is associated with an increased prevalence of metabolic syndrome, while postmenopausal hormone therapy is associated with a lower prevalence of metabolic syndrome in women with natural menopause.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
- Department of Pharmacology, Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Department of Psychiatry, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.
- Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
- Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung 81267, Taiwan.
ORCID-Profile: Shu-Pin Huang, Szu-Chia Chen, Jiun-Hung Geng, Chia-Hung Su
Förderung
- Kaohsiung Medical University
- Research Center for Precision Environmental Medicine
- Ministry of Education (MOE)
- Kaohsiung Medical University Research Center Grants
Zitieren
APA
Ou, Y. J., Lee, J. I., Huang, S. P., Chen, S. C., Geng, J. H., & Su, C. H. (2023). Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome. Journal of Clinical Medicine, 12(13), 4435. https://doi.org/10.3390/jcm12134435
Vancouver
Ou YJ, Lee JI, Huang SP, Chen SC, Geng JH, Su CH. Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome. Journal of Clinical Medicine. 2023;12(13):4435. doi:10.3390/jcm12134435
BibTeX
@article{Ou2023,
author = {Ou, Ying-Ju and Lee, Jia-In and Huang, Shu-Pin and Chen, Szu-Chia and Geng, Jiun-Hung and Su, Chia-Hung},
title = {Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4435},
doi = {10.3390/jcm12134435}
}
EUVIMED